Mn Services Vermogensbeheer B.V. Has $23.67 Million Stock Holdings in Colgate-Palmolive Company $CL

Mn Services Vermogensbeheer B.V. lifted its position in shares of Colgate-Palmolive Company (NYSE:CL) by 2.8% during the fourth quarter, HoldingsChannel reports. The firm owned 299,488 shares of the company’s stock after buying an additional 8,069 shares during the quarter. Mn Services Vermogensbeheer B.V.’s holdings in Colgate-Palmolive were worth $23,666,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. ProShare Advisors LLC raised its position in shares of Colgate-Palmolive by 11.0% during the third quarter. ProShare Advisors LLC now owns 2,047,542 shares of the company’s stock worth $163,681,000 after purchasing an additional 202,379 shares during the period. Providence Capital Advisors LLC bought a new position in shares of Colgate-Palmolive during the 3rd quarter valued at about $5,373,000. Asset Management One Co. Ltd. grew its position in shares of Colgate-Palmolive by 3.9% in the 3rd quarter. Asset Management One Co. Ltd. now owns 422,292 shares of the company’s stock valued at $33,758,000 after purchasing an additional 16,017 shares during the period. Citigroup Inc. increased its stake in Colgate-Palmolive by 43.7% during the 3rd quarter. Citigroup Inc. now owns 1,346,590 shares of the company’s stock worth $107,646,000 after purchasing an additional 409,710 shares in the last quarter. Finally, TD Waterhouse Canada Inc. raised its holdings in Colgate-Palmolive by 248.5% during the 3rd quarter. TD Waterhouse Canada Inc. now owns 87,410 shares of the company’s stock worth $6,909,000 after buying an additional 62,327 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on CL. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, January 21st. Deutsche Bank Aktiengesellschaft upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and raised their price objective for the stock from $90.00 to $98.00 in a report on Monday. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $100.00 price objective on shares of Colgate-Palmolive in a research report on Friday, February 20th. Wall Street Zen cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Sunday. Finally, Barclays lifted their price target on Colgate-Palmolive from $83.00 to $88.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 3rd. Eleven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $95.19.

Insider Buying and Selling at Colgate-Palmolive

In related news, insider John Hazlin sold 20,989 shares of Colgate-Palmolive stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total value of $1,978,213.25. Following the sale, the insider owned 17,645 shares of the company’s stock, valued at approximately $1,663,041.25. The trade was a 54.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Sally Massey sold 15,851 shares of the company’s stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the sale, the insider owned 13,751 shares in the company, valued at $1,306,757.53. The trade was a 53.55% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 184,683 shares of company stock valued at $17,486,693. Corporate insiders own 0.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of CL opened at $85.31 on Wednesday. The stock has a market capitalization of $68.44 billion, a P/E ratio of 32.56, a P/E/G ratio of 3.84 and a beta of 0.28. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The company has a 50 day moving average of $91.13 and a 200-day moving average of $83.40. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. During the same quarter in the previous year, the firm posted $0.91 earnings per share. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. As a group, equities research analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be given a dividend of $0.53 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend is Monday, April 20th. This represents a $2.12 annualized dividend and a yield of 2.5%. Colgate-Palmolive’s payout ratio is presently 80.92%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.